What was recalled
This page synthesizes the Shiga-toxin-producing E. coli (STEC) surveillance framework in commercial raw pet food. STEC is a category of Escherichia coli serotypes that produce shiga toxins (also known as verotoxins or vero cytotoxins), which target vascular endothelium in the gastrointestinal tract and kidneys producing severe acute disease in humans. The most-well-known STEC serotype is E. coli O157:H7, identified in the 1982 Jack in the Box hamburger outbreak and recognized as a major foodborne pathogen across human food (ground beef, leafy greens, unpasteurized dairy, others). The non-O157 STEC serotypes (collectively called the "Big Six": O26, O45, O103, O111, O121, O145) account for approximately 50% of STEC clinical cases and have been progressively recognized as significant pathogens through molecular epidemiology and improved detection methods.
The STEC prevalence in raw pet food is documented in FDA-CVM surveillance and academic literature at substantially lower rates than Salmonella. Specific reported rates vary across studies and product categories but consistently show STEC positivity in commercial raw pet food at <1-3% in surveillance sampling, compared to 5-25%+ Salmonella positivity in the same products. The lower STEC prevalence reflects: (i) STEC carriage in source cattle is lower than Salmonella prevalence across cattle, poultry, pork, and other source species; (ii) STEC concentrates in specific cattle slaughter byproduct categories (intestinal content, certain fat trimmings, hide cross-contamination during slaughter) more than in muscle meat; (iii) industry processing practices typically separate these higher-risk byproduct categories from raw pet food source ingredients more effectively than for Salmonella; (iv) STEC has narrower host species range than Salmonella (Salmonella affects many species; STEC primarily affects cattle, sheep, goats, and some wildlife as reservoirs).
The specific brand-level STEC recall events in raw pet food are less frequent than Salmonella recalls but have occurred across the 2010-2024 window. FDA periodically issues raw pet food recalls following STEC detection in routine surveillance sampling or following human clinical case investigation linking to specific products. The recall scope is typically narrower than major Salmonella recalls reflecting the lower prevalence pattern.
Why it was recalled
The structural concerns have three layers. Layer one — STEC produces severe per-case clinical disease: human infection with STEC, particularly O157:H7 and the non-O157 Big Six serotypes, produces severe acute illness including hemorrhagic colitis (bloody diarrhea, abdominal cramps, sometimes fever though many STEC infections are afebrile), hemolytic uremic syndrome (HUS) in approximately 5-10% of pediatric cases and lower percentages in adult cases, and (in severe cases) thrombotic thrombocytopenic purpura (TTP), permanent kidney damage, and mortality. The per-case clinical severity is substantially higher than Salmonella infection severity even though STEC infection is less common.
Layer two — vulnerable populations face disproportionate STEC risk: children under age 5 face elevated STEC risk with higher HUS rates and higher mortality. Elderly populations (typically >65 years) face elevated risk. Immunocompromised individuals face elevated risk. Pregnant women have specific STEC-related complications including preterm labor risk. Households with these vulnerable members face elevated risk from raw pet food handling and pet waste contamination compared to non-vulnerable households. The framework is similar to the Salmonella framework but with sharper per-case severity in vulnerable populations.
Layer three — STEC has lower antibiotic-treatment effectiveness: antibiotic treatment of STEC infection paradoxically increases HUS risk in some studies because antibiotic-induced bacterial lysis releases additional shiga toxin into the systemic circulation. Treatment is primarily supportive (fluid management, monitoring for HUS, dialysis if HUS develops). The limited treatment options elevate the importance of prevention through controlled raw pet food handling, kill-step adoption, and household risk assessment. The framework is covered in additional depth at our raw pet food zoonotic transmission page.
Health risks for your pet
The health-risk profile from STEC in raw pet food parallels the Salmonella framework but with higher per-case severity. Pet-direct risk is generally modest — dogs and cats appear less susceptible to STEC clinical disease than humans, with documented canine STEC clinical cases relatively rare. Pets can shed STEC asymptomatically following exposure to contaminated raw pet food, supporting the zoonotic transmission pathway. Zoonotic-to-human risk is the substantial concern: humans handling STEC-contaminated raw pet food, handling pet feeding bowls, or handling pet waste from STEC-shedding pets can acquire infection.
The per-case clinical outcome dimension matters substantially in framework design. A household with vulnerable members (young children, elderly, immunocompromised, pregnant) faces qualitatively different STEC risk from raw pet food than a healthy adult household; the lower probability of exposure must be weighed against the higher per-case clinical severity if exposure does occur. The framework supports more conservative raw pet food appropriateness assessment in vulnerable households even when overall STEC prevalence in raw pet food is lower than Salmonella prevalence.
What to do if you bought affected product
Pet owners considering or feeding raw pet food can take several practical approaches to manage STEC risk: (1) recognize STEC is a lower-frequency but higher-severity pathogen compared to Salmonella in raw pet food — the framework distinct from the broader Salmonella framework but operates in parallel; (2) assess household STEC vulnerability separately from general infection risk — households with children under age 5, elderly members over 65, immunocompromised members, or pregnant women face disproportionate STEC risk and should weigh raw pet food appropriateness more conservatively; (3) practice strict handling hygiene — the same handling practices that reduce Salmonella zoonotic risk apply to STEC: thorough hand washing, sanitization of food preparation surfaces, separation of raw pet food handling from human food preparation, cleaning and sanitization of pet feeding bowls; (4) select manufacturers using HPP or other documented kill-step technology — HPP achieves approximately 3-5 log STEC reduction (similar to Salmonella reduction); HPP-treated raw pet food has substantially lower STEC residual risk; (5) be cautious about cattle-source raw pet food specifically — STEC prevalence is higher in cattle source ingredients than in poultry source; beef-based and tripe-based raw pet food carries somewhat elevated STEC risk relative to chicken-based or turkey-based; (6) monitor pets and household members for STEC symptoms — bloody diarrhea in a raw-fed pet warrants veterinary evaluation including STEC consideration; bloody diarrhea or HUS symptoms in a household member with raw pet food exposure warrants medical evaluation and disclosure of pet food exposure to support diagnosis; (7) consider non-raw alternatives for households with vulnerable members — gently-cooked, freeze-dried (with kill-step), dry kibble, or canned wet pet food eliminate or substantially reduce STEC risk while supporting many nutritional and palatability goals.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 evaluates raw pet food per our published methodology — STEC surveillance status is considered indirectly through manufacturer QC and processing factors but does not directly determine rubric grade. The framework is covered alongside parallel raw-feeding pathogen frameworks at our Salmonella raw pet food surveillance, Listeria raw pet food controversy, Campylobacter raw pet food, raw pet food zoonotic transmission, and HPP validation controversy pages.